Medscape19 天
Intravenous metronidazole for the treatment of Clostridium difficile colitis.
Stimulated by several case reports in which intravenous metronidazole was used, we reviewed our experience. METHODS: Using pharmacy and microbiology laboratory records, we retrospectively ...
Monthly Prescribing Reference6 个月
Metronidazole Injection
Metronidazole 500mg/100mL; soln for IV infusion; contains sodium. Metronidazole exerts antibacterial effects in an anaerobic environment against most obligate anaerobes. Once metronidazole enters ...
Clinical Advisor1 天
Emblaveo Approved for Intra-Abdominal Infections in Patients With Limited Options
Emblaveo is a fixed-dose IV treatment that combines aztreonam, a monobactam antibiotic, and avibactam, a β-lactamase inhibitor.
Pharmaceutical Technology on MSN2 天
FDA approves AbbVie’s Emblaveo for intra-abdominal infections
AbbVie has received US Food and Drug Administration (FDA) approval for Emblaveo (aztreonam and avibactam) to be used in ...
AbbVie: FDA Approves Emblaveo - Metronidazole Combination For Complicated Intra-Abdominal ...
AbbVie (ABBV) announced the U.S. Food and Drug Administration approval of Emblaveo (aztreonam and avibactam). This marks the first ...
AbbVie says FDA approves Emblaveo in combination with metronidazole in adults
AbbVie (ABBV) announced that the U.S. Food and Drug Administration has approved EMBLAVEO, as the first and only fixed-dose, intravenous, ...
Medscape7 个月
An Unexpected Adverse Drug Effect
Preservatives or other additives to intravenous, intramuscular, and topical medications may cause adverse reactions, including apparent allergic reactions. Persons prescribed metronidazole (Flagyl ...
AbbVie gets FDA approval for antibiotic treatment Emblaveo (update)
AbbVie (NYSE:ABBV) said it has received FDA approval for its intravenous antibiotic treatment Emblaveo. The FDA approved Emblaveo, a combination of aztreonam and avibactam, for use in combination with ...